RD162 is used in medical and pharmacological research, particularly in studying the mechanisms of the nervous system and brain. It is a compound designed to investigate CB1-type cannabinoid receptors, which are involved in various neurological processes such as pain, anxiety, and memory. The use of RD162 in laboratory settings enables scientists to better understand the endocannabinoid system and develop more effective novel therapeutics for treating neurological disorders.